XML 29 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Investments
 3 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Investments Investments
The Company’s investments on the consolidated balance sheet include both available-for-sale and held-to-maturity debt securities (see Investments section below). The Company classifies its investments in equity securities of publicly traded and privately held companies within other assets on the consolidated balance sheet (see Equity Investments section below).
Investments
Investments on the consolidated balance sheet consisted of the following:
March 31,
2023		December 31,
2022
(in millions)
Available-for-sale securities 1
$271 $272 
Held-to-maturity securities 2
131 128 
Total investments $402 $400 
1See Available-for-Sale Securities section below for further detail.
2The cost of these securities approximates fair value.
Available-for-Sale Securities
The major classes of the Company’s available-for-sale investment securities and their respective amortized cost basis and fair values were as follows:
 March 31, 2023December 31, 2022
 Amortized
Cost		Gross
Unrealized
Gain		Gross
Unrealized
Loss		Fair
Value		Amortized
Cost		Gross
Unrealized
Gain		Gross
Unrealized
Loss		Fair
Value
(in millions)
Government and agency securities$96 $— $(1)$95 $91 $— $(2)$89 
Corporate securities179 — (3)176 187 — (4)183 
Total$275 $— $(4)$271 $278 $— $(6)$272 
The Company’s government and agency securities include U.S. government bonds, U.S. government sponsored agency bonds and foreign government bonds which are denominated in the national currency of the issuing country. Corporate available-for-sale investment securities held at March 31, 2023 and December 31, 2022 primarily carried a credit rating of A- or better. Corporate securities are comprised of commercial paper and corporate bonds. Unrealized gains and losses are recorded as a separate component of other comprehensive income (loss) on the consolidated statement of comprehensive income.
The maturity distribution based on the contractual terms of the Company’s available-for-sale investment securities at March 31, 2023 was as follows:
 
 Amortized CostFair Value
 (in millions)
Due within 1 year$156 $155 
Due after 1 year through 5 years119 116 
Total$275 $271 
Investment income on the consolidated statement of operations primarily consists of interest income generated from cash, cash equivalents, time deposits and available-for-sale investment securities, as well as realized gains and losses on the Company’s investment securities. The realized gains and losses from the sales of available-for-sale securities for the three months ended March 31, 2023 and 2022 were not material.
Equity Investments
Included in other assets on the consolidated balance sheet are equity investments with readily determinable fair values (“Marketable securities”) and equity investments without readily determinable fair values (“Nonmarketable securities”). Marketable securities are equity interests in publicly traded companies and are measured using unadjusted quoted prices in their respective active markets. Nonmarketable securities that do not qualify for equity method accounting are measured at cost, less any impairment and adjusted for changes resulting from observable price changes in orderly transactions for the identical or similar investments of the same issuer (“Measurement alternative”).
The following table is a summary of the activity related to the Company’s equity investments:
 Balance at December 31, 2022PurchasesSales
Changes in Fair Value 1
Other 2
Balance at March 31, 2023
(in millions)
Marketable securities $399 $— $— $(66)$3 $336 
Nonmarketable securities1,331 22 (44)(146)4 1,167 
Total equity investments $1,730 $22 $(44)$(212)$7 $1,503 
1Recorded in gains (losses) on equity investments, net on the consolidated statement of operations.
2Includes translational impact of currency.
The following table sets forth the components of the Company’s Nonmarketable securities:
March 31,
2023		December 31,
2022
(in millions)
Measurement alternative
$958 $1,087 
Equity method
209 244 
Total Nonmarketable securities$1,167 $1,331 
The following table summarizes the total carrying value of the Company’s Measurement alternative investments, including cumulative unrealized gains and losses through March 31, 2023:
(in millions)
Initial cost basis
$504 
Cumulative adjustments 1:
Upward adjustments620 
Downward adjustments (including impairment)(166)
Carrying amount, end of period$958 
1 Includes immaterial translational impact of currency.
The following table summarizes the unrealized gains and losses included in the carrying value of the Company’s Measurement alternative investments and Marketable securities for the three months ended March 31, 2023 and 2022:
Three Months Ended March 31,
20232022
(in millions)
Measurement alternative investments:
Upward adjustments$— $86 
Downward adjustments (including impairment)(133)— 
Marketable securities:
Unrealized gains (losses), net(66)(162)